rts logo

Novavax, Inc. (NVAX) Stock Could Soon Reward Patient Investors

Novavax, Inc. (NASDAQ: NVAX) is -3.13% lower on its value in year-to-date trading and has touched a low of $3.53 and a high of $11.36 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVAX stock was last observed hovering at around $4.78 in the last trading session, with the day’s loss setting it -0.13%.

Currently trading at $4.65, the stock is -9.10% and 0.94% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.36 million and changing -2.72% at the moment leaves the stock -26.71% off its SMA200. NVAX registered -30.18% loss for a year compared to 6-month loss of -35.06%. The firm has a 50-day simple moving average (SMA 50) of $0.56 and a 200-day simple moving average (SMA200) of -$0.64.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The stock witnessed a -5.87% gain in the last 1 month and extending the period to 3 months gives it a -5.30%, and is -1.06% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.58% over the week and 7.03% over the month.

Novavax, Inc. (NVAX) has around 1543 employees, a market worth around $650.77M and $983.71M in sales. Fwd P/E is 37.70. Profit margin for the company is -55.41%. Distance from 52-week low is 31.64% and -59.07% from its 52-week high.

Novavax, Inc. quarterly earnings per share for the current quarter are estimated at -$0.95 with sales reaching $101.45M over the same period.The EPS is expected to grow by 85.27% this year, but quarterly earnings will post -13.60% year-over-year. Quarterly sales are estimated to grow 25.30% in year-over-year returns.

Novavax, Inc. (NVAX) Top Institutional Holders

281 institutions hold shares in Novavax, Inc. (NVAX), with institutional investors hold 59.28% of the company’s shares. The shares outstanding are 139.51M, and float is at 131.81M with Short Float at 36.51%. Institutions hold 56.32% of the Float.

The top institutional shareholder in the company is State Street Corporation with over 11.68 million shares valued at $86.78 million. The investor’s holdings represent 12.37% of the NVAX Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 10.57 million shares valued at $78.55 million to account for 11.20% of the shares outstanding. The other top investors are Blackrock Inc. which holds 6.99 million shares representing 7.41% and valued at over $51.97 million, while Shah Capital Management holds 6.71% of the shares totaling 6.33 million with a market value of $45.83 million.

Related Posts